Metformin Auxilto

Metformin, the active ingredient in Metformin Auxilto, is a Biguanide presented as an oral tablet for oral use. It lowers blood glucose levels and is primarily prescribed for adults with type 2 diabetes mellitus, helping improve glycaemic control when used alongside diet and exercise. Metformin works by reducing hepatic glucose production and increasing peripheral insulin sensitivity, which together contribute to better metabolic balance.

GNH USA supplies Metformin Auxilto as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is indicated for conditions related to impaired glucose regulation and type 2 diabetes management.

Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial blood glucose levels. Prediabetes (impaired fasting glucose): delays progression to type 2 diabetes when combined with lifestyle modification. Polycystic ovary syndrome (PCOS): helps reduce insulin resistance and may improve menstrual regularity.

Metformin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea or abdominal discomfort - Diarrhea - Metallic taste in the mouth

Serious or Rare Side Effects: - Lactic acidosis (potentially fatal) - Severe skin reactions such as Stevens‑Johnson syndrome - Hepatic failure

Metformin requires careful monitoring and patient education before and during therapy.

Renal function: assess creatinine clearance before initiating therapy and periodically thereafter. Hepatic function: avoid use in patients with significant liver disease. Alcohol consumption: limit intake to reduce risk of lactic acidosis. Elderly patients: start at lower dose and monitor for intolerance. Vitamin B12 levels: monitor periodically as long‑term use may cause deficiency. Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate lactic acidosis; discontinue metformin before and after imaging. - Cimetidine: can increase metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Diuretics (especially thiazides): can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function when combined.